{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T12:19:33Z","timestamp":1775218773900,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,26]],"date-time":"2023-08-26T00:00:00Z","timestamp":1693008000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","redjournal.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.ijrobp.2023.08.048","type":"journal-article","created":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T16:08:59Z","timestamp":1693325339000},"page":"404-414","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Multicenter Phase 1b\/2a Clinical Trial of Radioprotectant BIO 300 Oral Suspension for Patients With Non-Small Cell Lung Cancer Receiving Concurrent Chemoradiotherapy"],"prefix":"10.1016","volume":"118","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0867-3694","authenticated-orcid":false,"suffix":"II","given":"Charles B.","family":"Simone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2683-4383","authenticated-orcid":false,"given":"Artur A.","family":"Serebrenik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth M.","family":"Gore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pranshu","family":"Mohindra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen L.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ding","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Indrin J.","family":"Chetty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeljko","family":"Vujaskovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Smitha","family":"Menon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gil","family":"Fine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael D.","family":"Kaytor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Movsas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2023.08.048_bib0001","unstructured":"National Cancer Institute. Surveillance, Epidemiology and End Results Program. Available at: www.seer.cancer.gov. Accessed December 26, 2022."},{"key":"10.1016\/j.ijrobp.2023.08.048_bib0002","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3322\/caac.21349","article-title":"Cancer treatment and survivorship statistics, 2016","volume":"66","author":"Miller","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ijrobp.2023.08.048_bib0003","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/imj.12138","article-title":"Outcomes of chemoradiation for patients with locally advanced non-small-cell lung cancer","volume":"43","author":"Spina","year":"2013","journal-title":"Intern Med J"},{"key":"10.1016\/j.ijrobp.2023.08.048_bib0004","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ijrobp.2012.04.043","article-title":"Predicting radiation pneumonitis after chemoradiation therapy for lung cancer: An international individual patient data meta-analysis","volume":"85","author":"Palma","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.08.048_bib0005","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.semradonc.2017.04.009","article-title":"Thoracic radiation normal tissue injury","volume":"27","author":"Simone","year":"2017","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2023.08.048_bib0006","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/acm2.13150","article-title":"Treatment planning and outcomes effects of reducing the preferred mean esophagus dose for conventionally fractionated non-small cell lung cancer radiotherapy","volume":"22","author":"Yorke","year":"2021","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.ijrobp.2023.08.048_bib0007","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.radonc.2019.01.003","article-title":"Predicting radiation pneumonitis in locally advanced stage II-III non-small cell lung cancer using machine learning","volume":"133","author":"Luna","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2023.08.048_bib0008","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3390\/cancers9090120","article-title":"Acute and late toxicities of concurrent chemoradiotherapy for locally-advanced non-small cell lung cancer","volume":"9","author":"Verma","year":"2017","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijrobp.2023.08.048_bib0009","first-page":"69","article-title":"Machine learning highlights the deficiency of conventional dosimetric constraints for prevention of high-grade radiation esophagitis in non-small cell lung cancer treated with chemoradiation","volume":"22","author":"Luna","year":"2020","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2023.08.048_bib0010","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/jrr\/rrz014","article-title":"Mechanism and therapeutic window of a genistein nanosuspension to protect against hematopoietic-acute radiation syndrome","volume":"60","author":"Landauer","year":"2019","journal-title":"J Radiat Res"},{"key":"10.1016\/j.ijrobp.2023.08.048_bib0011","doi-asserted-by":"crossref","first-page":"4738","DOI":"10.1111\/bph.14056","article-title":"BIO 300, a nanosuspension of genistein, mitigates pneumonitis\/fibrosis following high-dose radiation exposure in the C57l\/J murine model","volume":"174","author":"Jackson","year":"2017","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ijrobp.2023.08.048_bib0012","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1152\/physrev.00026.2006","article-title":"Estrogen receptors: How do they signal and what are their targets","volume":"87","author":"Heldring","year":"2007","journal-title":"Physiol Rev"},{"key":"10.1016\/j.ijrobp.2023.08.048_bib0013","doi-asserted-by":"crossref","first-page":"50002","DOI":"10.18632\/oncotarget.18442","article-title":"Therapeutic utility of natural estrogen receptor beta agonists on ovarian cancer","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ijrobp.2023.08.048_bib0014","doi-asserted-by":"crossref","first-page":"40","DOI":"10.18632\/oncotarget.5377","article-title":"ER\u03b2 regulation of NF-kB activation in prostate cancer is mediated by HIF-1","volume":"6","author":"Mak","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ijrobp.2023.08.048_bib0015","doi-asserted-by":"crossref","first-page":"24185","DOI":"10.1038\/srep24185","article-title":"Selective estrogen receptor beta agonist LY500307 as a novel therapeutic agent for glioblastoma","volume":"6","author":"Sareddy","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijrobp.2023.08.048_bib0016","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1667\/RR1896.1","article-title":"Genistein can mitigate the effect of radiation on rat lung tissue","volume":"173","author":"Calveley","year":"2010","journal-title":"Radiat Res"},{"key":"10.1016\/j.ijrobp.2023.08.048_bib0017","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1667\/RR3326.1","article-title":"Genistein nanoparticles protect mouse hematopoietic system and prevent proinflammatory factors after gamma irradiation","volume":"180","author":"Ha","year":"2013","journal-title":"Radiat Res"},{"key":"10.1016\/j.ijrobp.2023.08.048_bib0018","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1080\/09553002.2021.1981556","article-title":"A novel oral formulation of BIO 300 confers prophylactic radioprotection from acute radiation syndrome in mice","volume":"98","author":"Singh","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.08.048_bib0019","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s42523-021-00132-1","article-title":"Microbiome study in irradiated mice treated with BIO 300, a promising radiation countermeasure","volume":"3","author":"Cheema","year":"2021","journal-title":"Anim Microbiome"},{"key":"10.1016\/j.ijrobp.2023.08.048_bib0020","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.tips.2016.10.006","article-title":"Estrogen receptor beta as a pharmaceutical target","volume":"38","author":"Warner","year":"2017","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.ijrobp.2023.08.048_bib0021","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ijrobp.2019.05.062","article-title":"BIO 300, a nanosuspension of genistein, mitigates radiation-induced erectile dysfunction and sensitizes human prostate cancer xenografts to radiation therapy","volume":"105","author":"Jackson","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.08.048_bib0022","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.2174\/187152012803833107","article-title":"Bioavailability and pharmacokinetics of genistein: Mechanistic studies on its ADME","volume":"12","author":"Yang","year":"2012","journal-title":"Anticancer Agents Med Chem"},{"key":"10.1016\/j.ijrobp.2023.08.048_bib0023","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S1470-2045(14)71207-0","volume":"16","author":"Bradley","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2023.08.048_bib0024","first-page":"566","article-title":"Variability in human cytochrome p450 paclitaxel metabolism","volume":"275","author":"Sonnichsen","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.ijrobp.2023.08.048_bib0025","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1445-5994.1996.tb01925.x","article-title":"Carboplatin dosing based on measurement of renal function\u2014experience at the Peter Maccallum Cancer Institute","volume":"26","author":"Millward","year":"1996","journal-title":"Aust N Z J Med"},{"key":"10.1016\/j.ijrobp.2023.08.048_bib0026","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ygyno.2007.10.029","article-title":"Expression and activity of taxane-metabolizing enzymes in ovarian tumors","volume":"108","author":"DeLoia","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijrobp.2023.08.048_bib0027","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00228-010-0964-5","article-title":"Genistein alters caffeine exposure in healthy female volunteers","volume":"67","author":"Chen","year":"2011","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.ijrobp.2023.08.048_bib0028","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ijpharm.2007.01.002","article-title":"Effect of genistein on the pharmacokinetics of paclitaxel administered orally or intravenously in rats","volume":"337","author":"Li","year":"2007","journal-title":"Int J Pharm"},{"key":"10.1016\/j.ijrobp.2023.08.048_bib0029","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1001\/jamaoncol.2015.3969","article-title":"Quality of life analysis of a radiation dose-escalation study of patients with non-small-cell lung cancer: A secondary analysis of the Radiation Therapy Oncology Group 0617 randomized clinical trial","volume":"2","author":"Movsas","year":"2016","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ijrobp.2023.08.048_bib0030","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2023.08.048_bib0031","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1634\/theoncologist.2009-S101","article-title":"Targeting the TGF-beta1 pathway to prevent normal tissue injury after cancer therapy","volume":"15","author":"Anscher","year":"2010","journal-title":"Oncologist"},{"key":"10.1016\/j.ijrobp.2023.08.048_bib0032","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1748-717X-4-59","article-title":"The TGF-beta1 dynamics during radiation therapy and its correlation to symptomatic radiation pneumonitis in lung cancer patients","volume":"4","author":"Kim","year":"2009","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2023.08.048_bib0033","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1158\/1078-0432.CCR-10-1402","article-title":"Decreasing the adverse effects of cancer therapy: National Cancer Institute guidance for the clinical development of radiation injury mitigators","volume":"17","author":"Movsas","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2023.08.048_bib0034","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0895-4356(01)00477-2","article-title":"What is a clinically meaningful change on the Functional Assessment of Cancer Therapy-Lung (FACT-l) questionnaire? Results from Eastern Cooperative Oncology Group (ECOG) study 5592","volume":"55","author":"Cella","year":"2002","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ijrobp.2023.08.048_bib0035","doi-asserted-by":"crossref","first-page":"999","DOI":"10.21037\/tlcr-22-856","article-title":"The radioprotectant nano-genistein enhances radiotherapy efficacy of lung tumors in mice","volume":"12","author":"Kaytor","year":"2023","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.ijrobp.2023.08.048_bib0036","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1001\/jamaoncol.2016.4280","article-title":"Comparison of concurrent use of thoracic radiation with either carboplatin-paclitaxel or cisplatin-etoposide for patients with stage III non-small-cell lung cancer: A systematic review","volume":"3","author":"Steuer","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ijrobp.2023.08.048_bib0037","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.lungcan.2021.01.022","article-title":"Association of severe lymphopenia and disease progression in unresectable locally advanced non-small cell lung cancer treated with definitive chemoradiation and immunotherapy","volume":"154","author":"Friedes","year":"2021","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ijrobp.2023.08.048_bib0038","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1007\/s00432-012-1284-1","article-title":"Prediction of radiation pneumonitis in lung cancer patients: A systematic review","volume":"138","author":"Zhang","year":"2012","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.ijrobp.2023.08.048_bib0039","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejca.2016.03.081","article-title":"RECIST 1.1-update and clarification: From the RECIST committee","volume":"62","author":"Schwartz","year":"2016","journal-title":"Eur J Cancer"}],"updated-by":[{"DOI":"10.1016\/j.ijrobp.2024.02.009","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000}}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301623078458?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301623078458?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T20:59:14Z","timestamp":1705179554000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301623078458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S0360301623078458"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2023.08.048","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.ijrobp.2024.02.009","asserted-by":"object"}]},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multicenter Phase 1b\/2a Clinical Trial of Radioprotectant BIO 300 Oral Suspension for Patients With Non-Small Cell Lung Cancer Receiving Concurrent Chemoradiotherapy","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2023.08.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}